Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994968455> ?p ?o ?g. }
- W2994968455 abstract "The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as monotherapy in 2015 for aRCC after treatment with a VEGF-targeting agent. In April 2018, the combination of nivolumab and ipilimumab, a CTLA-4 inhibitor, was approved for intermediate- and poor-risk, previously untreated patients with aRCC. Then, in 2019, combinations therapies consisting of pembrolizumab (anti-PD-1) or avelumab (anti-PD-ligand (L) 1) with axitinib (a VEGF receptor tyrosine kinase inhibitor) were also approved to treat aRCC and are likely to produce dramatic shifts in the therapeutic landscape. To address the rapid advances in immunotherapy options for patients with aRCC, the Society for Immunotherapy of Cancer (SITC) reconvened its Cancer Immunotherapy Guidelines (CIG) Renal Cell Carcinoma Subcommittee and tasked it with generating updated consensus recommendations for the treatment of patients with this disease." @default.
- W2994968455 created "2019-12-26" @default.
- W2994968455 creator A5007052233 @default.
- W2994968455 creator A5007689146 @default.
- W2994968455 creator A5008174951 @default.
- W2994968455 creator A5017537551 @default.
- W2994968455 creator A5020223699 @default.
- W2994968455 creator A5025529463 @default.
- W2994968455 creator A5031088617 @default.
- W2994968455 creator A5034715033 @default.
- W2994968455 creator A5039495553 @default.
- W2994968455 creator A5041033274 @default.
- W2994968455 creator A5047602239 @default.
- W2994968455 creator A5050649350 @default.
- W2994968455 creator A5052526230 @default.
- W2994968455 creator A5059063118 @default.
- W2994968455 creator A5060348071 @default.
- W2994968455 creator A5072800302 @default.
- W2994968455 creator A5081174035 @default.
- W2994968455 creator A5091859782 @default.
- W2994968455 date "2019-12-01" @default.
- W2994968455 modified "2023-10-17" @default.
- W2994968455 title "The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)" @default.
- W2994968455 cites W1826925790 @default.
- W2994968455 cites W1952173328 @default.
- W2994968455 cites W1955656308 @default.
- W2994968455 cites W2018652183 @default.
- W2994968455 cites W2042457667 @default.
- W2994968455 cites W2099752220 @default.
- W2994968455 cites W2100158834 @default.
- W2994968455 cites W2100274893 @default.
- W2994968455 cites W2102900043 @default.
- W2994968455 cites W2108034855 @default.
- W2994968455 cites W2108389924 @default.
- W2994968455 cites W2113322173 @default.
- W2994968455 cites W2161550811 @default.
- W2994968455 cites W2193769500 @default.
- W2994968455 cites W2222086386 @default.
- W2994968455 cites W2284518822 @default.
- W2994968455 cites W2292835392 @default.
- W2994968455 cites W2327980272 @default.
- W2994968455 cites W2338576144 @default.
- W2994968455 cites W2346132749 @default.
- W2994968455 cites W2371138393 @default.
- W2994968455 cites W2373606074 @default.
- W2994968455 cites W2386935098 @default.
- W2994968455 cites W2401455386 @default.
- W2994968455 cites W2415125269 @default.
- W2994968455 cites W2469157980 @default.
- W2994968455 cites W2484090454 @default.
- W2994968455 cites W2487303921 @default.
- W2994968455 cites W2525217971 @default.
- W2994968455 cites W2529484692 @default.
- W2994968455 cites W2530419161 @default.
- W2994968455 cites W2549797787 @default.
- W2994968455 cites W2560367415 @default.
- W2994968455 cites W2591189187 @default.
- W2994968455 cites W2592144107 @default.
- W2994968455 cites W2593338436 @default.
- W2994968455 cites W2594042408 @default.
- W2994968455 cites W2606976048 @default.
- W2994968455 cites W2724506765 @default.
- W2994968455 cites W2735520635 @default.
- W2994968455 cites W2753890414 @default.
- W2994968455 cites W2760330862 @default.
- W2994968455 cites W2767856817 @default.
- W2994968455 cites W2770312776 @default.
- W2994968455 cites W2783708539 @default.
- W2994968455 cites W2785838318 @default.
- W2994968455 cites W2790175716 @default.
- W2994968455 cites W2792937256 @default.
- W2994968455 cites W2794685945 @default.
- W2994968455 cites W2800006085 @default.
- W2994968455 cites W2801270371 @default.
- W2994968455 cites W2805302875 @default.
- W2994968455 cites W2807297963 @default.
- W2994968455 cites W2888599070 @default.
- W2994968455 cites W2890014497 @default.
- W2994968455 cites W2890794399 @default.
- W2994968455 cites W2911812451 @default.
- W2994968455 cites W2913745075 @default.
- W2994968455 cites W2918019324 @default.
- W2994968455 cites W2921789044 @default.
- W2994968455 cites W2922202278 @default.
- W2994968455 cites W2943887705 @default.
- W2994968455 cites W2946942672 @default.
- W2994968455 cites W2948012083 @default.
- W2994968455 cites W2967350775 @default.
- W2994968455 doi "https://doi.org/10.1186/s40425-019-0813-8" @default.
- W2994968455 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6924043" @default.
- W2994968455 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31856918" @default.
- W2994968455 hasPublicationYear "2019" @default.
- W2994968455 type Work @default.
- W2994968455 sameAs 2994968455 @default.
- W2994968455 citedByCount "169" @default.
- W2994968455 countsByYear W29949684552020 @default.
- W2994968455 countsByYear W29949684552021 @default.
- W2994968455 countsByYear W29949684552022 @default.
- W2994968455 countsByYear W29949684552023 @default.
- W2994968455 crossrefType "journal-article" @default.